Filtered By:
Vaccination: Cervical Cancer Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 852 results found since Jan 2013.
Full eradication of pre-clinical human papilloma virus-induced tumors by a lentiviral vaccine
EMBO Mol Med. 2023 Sep 7:e17723. doi: 10.15252/emmm.202317723. Online ahead of print.ABSTRACTHuman papillomavirus (HPV) infections are the cause of all cervical and numerous oropharyngeal and anogenital cancers. The currently available HPV vaccines, which induce neutralizing antibodies, have no therapeutic effect on established tumors. Here, we developed an immuno-oncotherapy against HPV-induced tumors based on a non-integrative lentiviral vector encoding detoxified forms of the Early E6 and E7 oncoproteins of HPV16 and 18 genotypes, namely, "Lenti-HPV-07". A single intramuscular injection of Lenti-HPV-07 into mice bearing...
Source: Molecular Medicine - September 7, 2023 Category: Molecular Biology Authors: La ëtitia Douguet Ingrid Fert Jodie Lopez Benjamin Vesin Fabien Le Chevalier Fanny Moncoq Pierre Authi é Trang-My Nguyen Amandine Noirat Fabien N évo Catherine Blanc Maryline Bourgine David Hardy Fran çois Anna Laleh Majlessi Pierre Charneau Source Type: research
Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis
To eliminate cervical cancer as a public health problem, the World Health Organization had recommended routine vaccination of adolescent girls with two doses of the human papillomavirus (HPV) vaccine before se...
Source: BMC Medicine - August 28, 2023 Category: Internal Medicine Authors: Kiesha Prem, Yoon Hong Choi, Élodie Bénard, Emily A. Burger, Liza Hadley, Jean-François Laprise, Mary Caroline Regan, Mélanie Drolet, Stephen Sy, Kaja Abbas, Allison Portnoy, Jane J. Kim, Marc Brisson and Mark Jit Tags: Research article Source Type: research
A comparison of electronic health records and the Oregon state immunization registry for human papilloma virus vaccine delivery (2005-2022)
CONCLUSIONS: ALERT IIS data provides more accurate data than EHRs can provide when measuring vaccine delivery among adolescents in rural Oregon.PMID:37573204 | DOI:10.1016/j.vaccine.2023.08.017
Source: Vaccine - August 12, 2023 Category: Allergy & Immunology Authors: Sarah Bumatay Caitlin Dickinson Rex Larsen Isabel Stock Michael R Day Brigit Hatch Steven Robison Paul M Darden Eliana Sullivan Patricia A Carney Source Type: research
Perspectives on Human Papilloma Virus Vaccination Barriers, Knowledge and Beliefs, and Practices: Providers Serving Arab-American Populations
AbstractLittle is known of HPV vaccination (HPVV) recommendation practices among healthcare providers who treat the Arab American community. Evidence indicates that HPVV patient uptake is low in this population. A survey was administered to healthcare providers (N = 46, 63% response rate) who treated ≥ 5% Arab American patients aged 9–26 years in areas of New York City and New Jersey with large Arab American populations. They were asked about barriers to HPVV recommendation and uptake among their Arab American patients. Providers (Doctors of Medi cine and Osteopathy, Nurse Practitioners, and Physician Assistan...
Source: Journal of Community Health - August 9, 2023 Category: International Medicine & Public Health Source Type: research
Nonpediatric Specialties Face Smaller Return Margins for HPV Vaccine Costs
MONDAY, July 31, 2023 -- For nonpediatric specialties, return margins for human papillomavirus (HPV) vaccine costs by private payers are small, according to a study published in the July/August issue of the Annals of Family Medicine.
Yenan Zhu,...
Source: Drugs.com - Pharma News - July 31, 2023 Category: Pharmaceuticals Source Type: news
What Are Treatments for Recurrent Respiratory Papillomatosis?
Discussion
Human papilloma virus (HPV) is a member of the Papillomaviridae virus family with over a 150 different subtypes. HPV can cause cervical, genital and respiratory tract papillomas. HPV is often benign but can cause anogenital, cervical and head and neck cancers.
Recurrent respiratory papillomatosis (RRP) is uncommon but can cause significant morbidity while awaiting the body’s immune system to respond. There is a juvenile and adult form, and the incidence varies between 2-4/100,000 in the pediatric population. The juvenile form frequently occurs between 3.6-6 years of age and in general the younger the patie...
Source: PediatricEducation.org - July 31, 2023 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news
Protocol: carrageenan for the prevention of oral HPV infection - a feasibility randomised clinical trial
Introduction
Head and neck cancers (HNCs) are a significant health burden worldwide. Oral human papillomavirus (HPV) infection is a major risk factor for HNCs. Unfortunately, currently available prophylactic vaccines have limited coverage and potential for HPV type replacement. Carrageenan, a natural product extracted from marine red algae, has demonstrated potency as an HPV inhibitor and could offer a potential alternative to prevent HPV-related diseases, including oral HPV infection. However, there is a lack of clinical studies on the effect of carrageenan on oral HPV infections. As a first step to address this gap, we p...
Source: BMJ Open - July 27, 2023 Category: General Medicine Authors: Alli, B. Y., Madathil, S., Tran, S. D., Nicolau, B. Tags: Open access, Dentistry and oral medicine Source Type: research
Reimbursement for HPV Vaccine Cost in the Private Sector: A Comparison Across Specialties
This study found that net returns from HPV vaccine cost reimbursements are lowest for family physicians ($0.34/dose) and highest for pediatricians ($5.08/dose). Furthermore, a $1 increment in return was associated with an increase in HPV vaccine doses administered (highest for family physicians; 0.08% per dollar). Reimbursement for HPV vaccine costs by private payers is adequate; however, return margins are small for non-pediatric specialties.PMID:37487718 | PMC:PMC10365861 | DOI:10.1370/afm.2990
Source: Annals of Family Medicine - July 24, 2023 Category: Primary Care Authors: Yenan Zhu Yueh-Yun Lin Ruosha Li Cara He David R Lairson Ashish A Deshmukh Kalyani Sonawane Source Type: research
